Replies to post #3492 on EOM Pharmaceutical Holdings Inc. (IMUC)

[Investor100]

IMUC @ Stockcharts

This stock back on watchlist and will re-enter a position below.25

ImmunoCellular Therapeutics Treats First Patient in ICT-107 Phase 3 Registrational Trial in Newly Diagnosed Glioblastoma
https://finance.yahoo.com/news/immunocellular-therapeutics-treats-first-patient-100000860.html
ImmunoCellular has reached agreement with the US FDA on a Special Protocol Assessment (SPA) relative to the primary and secondary endpoints as well as the statistical plan for the phase 3 trial. ImmunoCellular has also been honored with a $19.9 million award from the governing Board of the California Institute for Regenerative Medicine (CIRM),




Investor 100